Key result
Advanced imaging techniques, particularly global longitudinal strain by speckle tracking echocardiography, enable early detection of chemotherapy-induced cardiotoxicity prior to declines in ejection fraction.
Why the study?
Do new imaging techniques (3D echo, speckle tracking, CMR) improve the early detection of chemotherapy-induced myocardial damage in cancer patients compared to classic imaging methods?
Do new imaging techniques (3D echo, speckle tracking, CMR) improve the early detection of chemotherapy-induced myocardial damage in cancer patients compared to classic imaging methods?
Advanced imaging techniques such as 3D echocardiography, speckle tracking, and cardiac magnetic resonance offer higher sensitivity than traditional LVEF assessment for the early detection of chemotherapy-induced cardiotoxicity.
Answers are grounded in this paper and cite their sources.
May support strain imaging for early cardiotoxicity surveillance; leaves open outcome impact pending prospective trials.
Cardiotoxicity represents a rising problem influencing prognosis and quality of life of chemotherapy-treated patients. Anthracyclines and trastuzumab are the drugs most commonly associated with development of a cardiotoxic effect. Heart failure, myocardial ischemia, hypertension, myocarditis, and thrombosis are typical manifestation of cardiotoxicity by chemotherapeutic agents. Diagnosis and monitoring of cardiac side-effects of cancer treatment is of paramount importance. Echocardiography and nuclear medicine methods are widely used in clinical practice and left ventricular ejection fraction is the most important parameter to asses myocardial damage secondary to chemotherapy. However, left ventricular ejection decrease is a delayed phenomenon, occurring after a long stage of silent myocardial damage that classic imaging methods are not able to detect. New imaging techniques including three-dimensional echocardiography, speckle tracking echocardiography, and cardiac magnetic resonance have demonstrated high sensitivity in detecting the earliest alteration of left ventricular function associated with future development of chemotherapy-induced cardiomyopathy. Early diagnosis of cardiac involvement in cancer patients can allow for timely and adequate treatment management and the introduction of cardioprotective strategies.
No takes yet. Share an insight, caveat, or question.
Pizzino et al. (2015) conducted a review in Chemotherapy-induced cardiotoxicity. Multimodality imaging (Echocardiography, CMR, Speckle Tracking) was evaluated. Advanced imaging techniques, particularly global longitudinal strain by speckle tracking echocardiography, enable early detection of chemotherapy-induced cardiotoxicity prior to declines in ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: